Delparantag, formerly known as PMX-60056, is a heparins antidote designed to restore coagulation to help manage the balance of antithrombosis and anticoagulation and reduce the incidence of bleeding in certain interventional cardiology procedures, such as Percutaneous Coronary Intervention (PCI) and Coronary Arterial Bypass Graft (CABG), as well as, treat bleeding associated with low molecular weight heparins. Delparantag reverses the most common anticoagulants used in the hospital setting, heparin, and its analogue, low molecular weight heparin (LMWH). References: Mahan CE. A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents. J Thromb Thrombolysis. 2014 Apr;37(3):271-8. doi: 10.1007/s11239-013-0927-7. PubMed PMID: 23653171.

纯度：≥98%

CAS：872454-31-4